| Year |
Citation |
Score |
| 2020 |
Caballero AR, Tang A, Bierdeman M, O'Callaghan R, Marquart M. Correlation of Phenotype and its Corneal Virulence. Current Eye Research. PMID 32938252 DOI: 10.1080/02713683.2020.1825748 |
0.432 |
|
| 2018 |
Tang A, Caballero AR, Marquart ME, Bierdeman MA, O'Callaghan RJ. Mechanism of Pseudomonas aeruginosa Small Protease (PASP), a Corneal Virulence Factor. Investigative Ophthalmology & Visual Science. 59: 5993-6002. PMID 30572344 DOI: 10.1167/Iovs.18-25834 |
0.401 |
|
| 2018 |
O'Callaghan RJ. The Pathogenesis of Staphylococcus aureus Eye Infections. Pathogens (Basel, Switzerland). 7. PMID 29320451 DOI: 10.3390/Pathogens7010009 |
0.456 |
|
| 2017 |
Bierdeman MA, Torres AM, Caballero AR, Tang A, O'Callaghan RJ. Reactions with Antisera and Pathological Effects of Staphylococcus aureus Gamma-Toxin in the Cornea. Current Eye Research. 1-8. PMID 28346009 DOI: 10.1080/02713683.2017.1279636 |
0.379 |
|
| 2015 |
Arana AM, Bierdeman MA, Balzli CL, Tang A, Caballero AR, Patel R, O'Callaghan RJ. Staphylococcus Alpha-Toxin Action on the Rabbit Iris: Toxic Effects and Their Inhibition. Current Eye Research. 40: 830-8. PMID 25266876 DOI: 10.3109/02713683.2014.959609 |
0.357 |
|
| 2013 |
Tang A, Caballero AR, Marquart ME, O'Callaghan RJ. Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor. Investigative Ophthalmology & Visual Science. 54: 2821-8. PMID 23548618 DOI: 10.1167/Iovs.13-11788 |
0.347 |
|
| 2013 |
Marquart ME, O'Callaghan RJ. Infectious keratitis: secreted bacterial proteins that mediate corneal damage. Journal of Ophthalmology. 2013: 369094. PMID 23365719 DOI: 10.1155/2013/369094 |
0.41 |
|
| 2012 |
Tang A, Balzli CL, Caballero AR, McCormick CC, Taylor SD, O'Callaghan RJ. Staphylococcus aureus infection of the rabbit cornea following topical administration. Current Eye Research. 37: 1075-83. PMID 22916736 DOI: 10.3109/02713683.2012.716485 |
0.311 |
|
| 2010 |
Balzli CL, Caballero AR, Tang A, Weeks AC, O'Callaghan RJ. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections. Journal of Cataract and Refractive Surgery. 36: 2160-7. PMID 21111321 DOI: 10.1016/J.Jcrs.2010.06.070 |
0.453 |
|
| 2010 |
Balzli CL, McCormick CC, Caballero AR, O'Callaghan RJ. Sustained anti-staphylococcal effect of lysostaphin in the rabbit aqueous humor. Current Eye Research. 35: 480-6. PMID 20465441 DOI: 10.3109/02713681003664949 |
0.306 |
|
| 2010 |
Balzli CL, Bartell J, Dajcs JJ, McCormick CC, Caballero AR, Stroman D, O'Callaghan RJ. A highly virulent Staphylococcus aureus: rabbit anterior chamber infection, characterization, and genetic analysis. Investigative Ophthalmology & Visual Science. 51: 5114-20. PMID 20463315 DOI: 10.1167/Iovs.10-5179 |
0.747 |
|
| 2009 |
McCormick CC, Caballero AR, Balzli CL, Tang A, O'Callaghan RJ. Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus. Investigative Ophthalmology & Visual Science. 50: 2848-54. PMID 19136695 DOI: 10.1167/Iovs.08-3157 |
0.356 |
|
| 2008 |
McCormick C, Caballero A, Tang A, Balzli C, Song J, O'Callaghan R. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis. Current Medical Research and Opinion. 24: 1569-75. PMID 18423106 DOI: 10.1185/03007990802079877 |
0.318 |
|
| 2008 |
Balzli CL, McCormick CC, Caballero AR, Huang B, Wigington L, Smith E, Tang A, O'Callaghan RJ. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis. Journal of Cataract and Refractive Surgery. 34: 295-301. PMID 18242457 DOI: 10.1016/J.Jcrs.2007.10.022 |
0.431 |
|
| 2007 |
Thibodeaux BA, Caballero AR, Marquart ME, Tommassen J, O'Callaghan RJ. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Current Eye Research. 32: 373-86. PMID 17453960 DOI: 10.1080/02713680701244181 |
0.394 |
|
| 2006 |
McCormick CC, Dajcs JJ, Reed JM, Marquart ME, O'Callaghan RJ. The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis. Current Eye Research. 31: 225-30. PMID 16531279 DOI: 10.1080/02713680500536753 |
0.714 |
|
| 2006 |
Caballero AR, Marquart ME, O'Callaghan RJ, Thibodeaux BA, Johnston KH, Dajcs JJ. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo. Current Eye Research. 31: 23-9. PMID 16421016 DOI: 10.1080/02713680500477321 |
0.714 |
|
| 2005 |
Thibodeaux BA, Caballero AR, Dajcs JJ, Marquart ME, Engel LS, O'Callaghan RJ. Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity. Ocular Immunology and Inflammation. 13: 169-82. PMID 16019676 DOI: 10.1080/09273940490518937 |
0.708 |
|
| 2005 |
Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. Effects of toxin production in a murine model of Staphylococcus aureus keratitis. Investigative Ophthalmology & Visual Science. 46: 2064-70. PMID 15914624 DOI: 10.1167/Iovs.04-0897 |
0.779 |
|
| 2005 |
Girgis DO, Reed JM, Monds KS, Dajcs JJ, Marquart ME, Thibodeaux BA, O'Callaghan RJ. Pathogenesis of Staphylococcus in the rabbit anterior chamber. Investigative Ophthalmology & Visual Science. 46: 1371-8. PMID 15790904 DOI: 10.1167/Iovs.04-0888 |
0.773 |
|
| 2005 |
Reed JM, O'Callaghan RJ, Girgis DO, McCormick CC, Caballero AR, Marquart ME. Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model. Investigative Ophthalmology & Visual Science. 46: 604-8. PMID 15671288 DOI: 10.1167/Iovs.04-0889 |
0.783 |
|
| 2005 |
Marquart ME, Dajcs JJ, Caballero AR, Thibodeaux BA, O'Callaghan RJ. Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factor. Medical Microbiology and Immunology. 194: 39-45. PMID 14628143 DOI: 10.1007/S00430-003-0207-9 |
0.68 |
|
| 2004 |
Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. Susceptibility of aged mice to Staphylococcus aureus keratitis. Current Eye Research. 29: 269-75. PMID 15590472 DOI: 10.1080/02713680490516783 |
0.755 |
|
| 2004 |
Thibodeaux BA, Dajcs JJ, Caballero AR, Marquart ME, Girgis DO, O'Callaghan RJ. Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis. Current Eye Research. 28: 337-42. PMID 15287370 DOI: 10.1076/Ceyr.28.5.337.28676 |
0.78 |
|
| 2004 |
Dajcs JJ, Thibodeaux BA, Marquart ME, Girgis DO, Traidej M, O'Callaghan RJ. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Antimicrobial Agents and Chemotherapy. 48: 1948-52. PMID 15155183 DOI: 10.1128/Aac.48.6.1948-1952.2004 |
0.773 |
|
| 2004 |
Caballero A, Thibodeaux B, Marquart M, Traidej M, O'Callaghan R. Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases. Investigative Ophthalmology & Visual Science. 45: 522-30. PMID 14744894 DOI: 10.1167/Iovs.03-1050 |
0.762 |
|
| 2003 |
O'Callaghan RJ, Girgis DO, Dajcs JJ, Sloop GD. Host defense against bacterial keratitis. Ocular Immunology and Inflammation. 11: 171-81. PMID 14566643 DOI: 10.1076/Ocii.11.3.171.17351 |
0.784 |
|
| 2003 |
Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. A new topical model of Staphylococcus corneal infection in the mouse. Investigative Ophthalmology & Visual Science. 44: 1591-7. PMID 12657597 DOI: 10.1167/Iovs.02-0656 |
0.781 |
|
| 2003 |
Girgis DO, Dajcs JJ, O'Callaghan RJ. Phospholipase A2 activity in normal and Staphylococcus aureus-infected rabbit eyes. Investigative Ophthalmology & Visual Science. 44: 197-202. PMID 12506075 DOI: 10.1167/Iovs.02-0548 |
0.779 |
|
| 2003 |
Traidej M, Caballero AR, Marquart ME, Thibodeaux BA, O'Callaghan RJ. Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida. Investigative Ophthalmology & Visual Science. 44: 190-6. PMID 12506074 DOI: 10.1167/Iovs.02-0458 |
0.76 |
|
| 2003 |
Traidej M, Marquart ME, Caballero AR, Thibodeaux BA, O'Callaghan RJ. Identification of the active site residues of Pseudomonas aeruginosa protease IV. Importance of enzyme activity in autoprocessing and activation. The Journal of Biological Chemistry. 278: 2549-53. PMID 12419815 DOI: 10.1074/Jbc.M208973200 |
0.752 |
|
| 2002 |
Dajcs JJ, Thibodeaux BA, Girgis DO, Shaffer MD, Delvisco SM, O'Callaghan RJ. Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit. Investigative Ophthalmology & Visual Science. 43: 3712-6. PMID 12454041 |
0.769 |
|
| 2002 |
Moreau JM, Conerly LL, Hume EB, Dajcs JJ, Girgis DO, Cannon BM, Thibodeaux BA, Stroman DW, O'Callaghan RJ. Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis. Cornea. 21: 807-11. PMID 12410042 DOI: 10.1097/00003226-200211000-00016 |
0.779 |
|
| 2002 |
Dajcs JJ, Thibodeaux BA, Girgis DO, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus in an experimental model of keratitis. Dna and Cell Biology. 21: 375-82. PMID 12167239 DOI: 10.1089/10445490260099656 |
0.781 |
|
| 2002 |
Dajcs JJ, Austin MS, Sloop GD, Moreau JM, Hume EB, Thompson HW, McAleese FM, Foster TJ, O'Callaghan RJ. Corneal pathogenesis of Staphylococcus aureus strain Newman. Investigative Ophthalmology & Visual Science. 43: 1109-15. PMID 11923253 |
0.746 |
|
| 2001 |
Dajcs JJ, Moreau JM, Stroman DW, Schlech BA, Ke TL, Thibodeaux BA, Girgis DO, Caballero AR, O'Callaghan RJ. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis. Current Eye Research. 23: 60-3. PMID 11821987 DOI: 10.1076/Ceyr.23.1.60.5417 |
0.808 |
|
| 2001 |
Hume EB, Dajcs JJ, Moreau JM, Sloop GD, Willcox MD, O'Callaghan RJ. Staphylococcus corneal virulence in a new topical model of infection. Investigative Ophthalmology & Visual Science. 42: 2904-8. PMID 11687535 |
0.74 |
|
| 2001 |
Dajcs JJ, Moreau JM, Thibodeaux BA, Traidej M, Austin MS, Marquart ME, Stroman DW, O'Callaghan RJ. Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis. Cornea. 20: 878-80. PMID 11685070 DOI: 10.1097/00003226-200111000-00020 |
0.773 |
|
| 2001 |
Dajcs JJ, Thibodeaux BA, Hume EB, Zheng X, Sloop GD, O'Callaghan RJ. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit. Current Eye Research. 22: 451-7. PMID 11584345 DOI: 10.1076/Ceyr.22.6.451.5486 |
0.758 |
|
| 2001 |
Moreau JM, Girgis DO, Hume EB, Dajcs JJ, Austin MS, O'Callaghan RJ. Phospholipase A(2) in rabbit tears: a host defense against Staphylococcus aureus. Investigative Ophthalmology & Visual Science. 42: 2347-54. PMID 11527949 |
0.775 |
|
| 2001 |
White CD, Alionte LG, Cannon BM, Caballero AR, O'Callaghan RJ, Hobden JA. Corneal virulence of LasA protease--deficient Pseudomonas aeruginosa PAO1. Cornea. 20: 643-6. PMID 11473168 DOI: 10.1097/00003226-200108000-00017 |
0.338 |
|
| 2001 |
Alionte LG, Cannon BM, White CD, Caballero AR, O'Callaghan RJ, Hobden JA. Pseudomonas aeruginosa LasA protease and corneal infections. Current Eye Research. 22: 266-71. PMID 11462165 DOI: 10.1076/Ceyr.22.4.266.5509 |
0.419 |
|
| 2000 |
Dajcs JJ, Hume EB, Moreau JM, Caballero AR, Cannon BM, O'Callaghan RJ. Lysostaphin treatment of methicillin-resistant staphylococcus aureus keratitis in the rabbit(1) American Journal of Ophthalmology. 130: 544. PMID 11024447 |
0.729 |
|
| 2000 |
Hume EB, Dajcs JJ, Moreau JM, O'Callaghan RJ. Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis. Infection and Immunity. 68: 6052-5. PMID 10992521 DOI: 10.1128/Iai.68.10.6052-6055.2000 |
0.724 |
|
| 2000 |
Dajcs JJ, Hume EB, Moreau JM, Caballero AR, Cannon BM, O'Callaghan RJ. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Investigative Ophthalmology & Visual Science. 41: 1432-7. PMID 10798659 |
0.739 |
|
| 1999 |
Hume EB, Conerly LL, Moreau JM, Cannon BM, Engel LS, Stroman DW, Hill JM, O'Callaghan RJ. Serratia marcescens keratitis: strain-specific corneal pathogenesis in rabbits. Current Eye Research. 19: 525-32. PMID 10550795 DOI: 10.1076/Ceyr.19.6.525.5283 |
0.333 |
|
| 1999 |
Hazlett LD, McClellan SM, Hume EB, Dajcs JJ, O'Callaghan RJ, Willcox MD. Extended wear contact lens usage induces Langerhans cell migration into cornea. Experimental Eye Research. 69: 575-7. PMID 10548479 DOI: 10.1006/Exer.1999.0728 |
0.674 |
|
| 1999 |
Hume EB, Moreau JM, Conerly LL, Cannon BM, Dajcs JJ, Hill JM, O'Callaghan RJ. Clarithromycin for experimental Staphylococcus aureus keratitis. Current Eye Research. 18: 358-62. PMID 10372997 DOI: 10.1076/Ceyr.18.5.358.5350 |
0.778 |
|
| 1999 |
Sloop GD, Moreau JM, Conerly LL, Dajcs JJ, O'Callaghan RJ. Acute inflammation of the eyelid and cornea in Staphylococcus keratitis in the rabbit. Investigative Ophthalmology & Visual Science. 40: 385-91. PMID 9950597 |
0.672 |
|
| 1998 |
Moreau JM, Green LC, Engel LS, Hill JM, O'Callaghan RJ. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model. Current Eye Research. 17: 808-12. PMID 9723996 DOI: 10.1080/02713689808951262 |
0.431 |
|
| 1998 |
Engel LS, Hill JM, Moreau JM, Green LC, Hobden JA, O'Callaghan RJ. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Investigative Ophthalmology & Visual Science. 39: 662-5. PMID 9501882 |
0.305 |
|
| 1997 |
Moreau JM, Sloop GD, Engel LS, Hill JM, O'Callaghan RJ. Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas. Current Eye Research. 16: 1221-8. PMID 9426955 DOI: 10.1076/Ceyr.16.12.1221.5022 |
0.375 |
|
| 1997 |
O'Callaghan RJ, Callegan MC, Moreau JM, Green LC, Foster TJ, Hartford OM, Engel LS, Hill JM. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infection and Immunity. 65: 1571-8. PMID 9125532 DOI: 10.1128/Iai.65.5.1571-1578.1997 |
0.401 |
|
| 1996 |
Engel LS, Callegan MC, Hill JM, Folkens AT, Shimomura Y, O'Callaghan RJ. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis Japanese Journal of Ophthalmology. 40: 212-219. PMID 8876389 |
0.348 |
|
| 1996 |
Green LC, Callegan MC, Engel LS, Shimomura Y, Jasheway DW, O'Callaghan RJ, Hill JM. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears Japanese Journal of Ophthalmology. 40: 123-126. PMID 8739510 |
0.316 |
|
| 1996 |
Engel LS, Green LC, Hobden JA, Callegan MC, Hill JM, O'Callaghan RJ. Protease IV activity in vitro correlates with Pseudomonas corneal virulence in vivo Investigative Ophthalmology and Visual Science. 37. |
0.301 |
|
| 1995 |
Engel LS, Callegan MC, Hobden JA, Reidy JJ, Hill JM, O'callaghan RJ. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental pseudomonas aeruginosa keratitis Current Eye Research. 14: 229-234. PMID 7796606 DOI: 10.3109/02713689509033519 |
0.408 |
|
| 1995 |
Callegan MC, Hobden JA, O'Callaghan RJ, Hill JM. Ocular drug delivery: A comparison of transcorneal iontophoresis to corneal collagen shields International Journal of Pharmaceutics. 123: 173-179. DOI: 10.1016/0378-5173(95)00048-N |
0.301 |
|
| 1994 |
Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus: Roles of alpha-toxin and protein A in pathogenesis Infection and Immunity. 62: 2478-2482. PMID 8188373 DOI: 10.1128/Iai.62.6.2478-2482.1994 |
0.437 |
|
| 1994 |
Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis Investigative Ophthalmology and Visual Science. 35: 1033-1037. PMID 8125714 |
0.33 |
|
| 1994 |
Callegan MC, Engel LS, Clinch TE, Hill JM, Kaufman HE, O'callaghan RJ. Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis Current Eye Research. 13: 875-878. PMID 7720394 DOI: 10.3109/02713689409015089 |
0.325 |
|
| 1993 |
Hobden JA, Engel LS, Hill JM, Callegan MC, O'Callaghan RJ. Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental pseudomonas aeruginosa keratitis Current Eye Research. 12: 469-473. PMID 8344070 DOI: 10.3109/02713689309024629 |
0.412 |
|
| 1993 |
Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. pseudomonas aeruginosa keratitis in leukopenic rabbits Current Eye Research. 12: 461-467. PMID 8344069 DOI: 10.3109/02713689309024628 |
0.39 |
|
| 1993 |
Hobden JA, Hill JM, Engel LS, O'Callaghan RJ. Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone, and flurbiprofen Antimicrobial Agents and Chemotherapy. 37: 1856-1859. PMID 8239596 DOI: 10.1128/Aac.37.9.1856 |
0.323 |
|
| 1993 |
Engel LS, Callegan MC, Hill JM, O'Callaghan RJ. Bioassays for quantitating ciprofloxacin and tobramycin in aqueous humor Journal of Ocular Pharmacology. 9: 311-320. PMID 8106837 DOI: 10.1089/Jop.1993.9.311 |
0.401 |
|
| 1992 |
Johnson MK, Hobden JA, O'Callaghan RJ, Hill JM. Confirmation of the role of pneumolysin in ocular infections with streptococcus pneumoniae Current Eye Research. 11: 1221-1225. PMID 1490340 DOI: 10.3109/02713689208999547 |
0.384 |
|
| 1992 |
Callegan MC, Hill JM, Insler MS, Hobden JA, O'Callaghan RJ. Methicillin-resistant staphylococcus aureus keratitis in the rabbit: Therapy with ciprofloxacin, vancomycin and cefazolin Current Eye Research. 11: 1111-1119. PMID 1483341 DOI: 10.3109/02713689209015083 |
0.487 |
|
| 1992 |
Callegan MC, Hobden JA, Hill JM, Insler MS, O'Callaghan RJ. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis Investigative Ophthalmology and Visual Science. 33: 3017-3023. PMID 1399405 |
0.321 |
|
| 1992 |
O'Callaghan R, Hobden J, Hill J. Corneal virulence of Pseudomonas mutants deficient in specific exoproteins Experimental Eye Research. 55: 209. DOI: 10.1016/0014-4835(92)90951-N |
0.324 |
|
| 1991 |
Insler MS, Fish LA, Silbernagel J, Hobden JA, O'Callaghan RJ, Hill JM. Successful treatment of methicillin-resistant Staphylococcus aureus Keratitis with topical ciprofloxacin. Ophthalmology. 98: 1690-2. PMID 1800931 DOI: 10.1016/S0161-6420(91)32067-0 |
0.449 |
|
| 1990 |
Johnson MK, Hobden JA, Hagenah M, O'callaghan RJ, Hill JM, Chen S. The role of pneumolysin in ocular infections with streptococcus pneumoniae Current Eye Research. 9: 1107-1114. PMID 2095322 DOI: 10.3109/02713689008997584 |
0.415 |
|
| 1989 |
Hobden JA, O'Callaghan RJ, Hill JM, Reidy JJ, Rootman DS, Thompson HW. Tobramycin iontophoresis into corneas infected with drug-resistant pseudomonas aeruginosa Current Eye Research. 8: 1163-1169. PMID 2515036 DOI: 10.3109/02713688909000041 |
0.425 |
|
| 1988 |
Hobden JA, Rootman DS, O'Callaghan RJ, Hill JM. Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas Antimicrobial Agents and Chemotherapy. 32: 978-981. PMID 3142344 DOI: 10.1128/Aac.32.7.978 |
0.372 |
|
| 1988 |
Rootman DS, Jantzen JA, Gonzalez JR, Hill JM, O'callaghan RJ, Hobden JA. Iontophoresis of Tobramycin for the Treatment of Experimental Pseudomonas Keratitis in the Rabbit Archives of Ophthalmology. 106: 262-265. PMID 3124801 DOI: 10.1001/Archopht.1988.01060130276043 |
0.384 |
|
| 1986 |
Lamousin-White M, O'Callaghan RJ. Association between colistin resistance and broad-spectrum recipient deficiency in Klebsiella pneumoniae Antimicrobial Agents and Chemotherapy. 30: 964-965. PMID 3545071 DOI: 10.1128/Aac.30.6.964 |
0.345 |
|
| 1980 |
Hardy DJ, Legeal RJ, O'Callaghan RJ. Klebsiella neonatal infections: Mechanism of broadening aminoglycoside resistance Antimicrobial Agents and Chemotherapy. 18: 542-548. PMID 7004341 DOI: 10.1128/Aac.18.4.542 |
0.397 |
|
| 1978 |
O'Callaghan RJ, Rousset KM, Harkess NK, Murray ML, Lewis AC, Williams WL. Analysis of increasing antibiotic resistance of Klebsiella pneumoniae relative to changes in chemotherapy. The Journal of Infectious Diseases. 138: 293-8. PMID 359724 DOI: 10.1093/Infdis/138.3.293 |
0.388 |
|
| 1969 |
O'Callaghan RJ, O'Mara W, Grogan JB. Physical stability and biological and physicochemical properties of twelve Pseudomonas aeruginosa bacteriophages Virology. 37: 642-648. PMID 4976536 DOI: 10.1016/0042-6822(69)90282-7 |
0.301 |
|
| Show low-probability matches. |